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Background: Prior studies on the association between prenatal exposure to polychlorinated biphenyls (PCBs) and
dichlorodiphenyldichloroethylene (DDE) and child motor development have found contradicting results. Using data
collected in the INUENDO cohort in Kharkiv (Ukraine), Warsaw (Poland) and Greenland (N = 1,103) between the
years 2002 and 2012, we examined relations of prenatal exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene
(p,p′-DDE) and 2,2′,4,4′,5,5′-hexachlorobiphenyl (CB-153) on motor development and developmental milestones;
crawling, standing-up and walking.
Methods: CB-153 and p,p′-DDE were measured in maternal blood in second or third trimester of pregnancy.
Motor development was measured in terms of the parentally assessed screening tool Developmental Coordination
Disorder Questionnaire 2007 and developmental milestones were assessed via retrospective parental reports of
child age at the first time of crawling, standing-up and walking.
Results: We saw no associations between tertiles of CB-153 and p,p′-DDE or log-transformed exposures and retrospective
reports of the developmental milestones crawling, standing-up and walking in infancy or the motor skills measured as
developmental coordination disorder at young school age.
Conclusions: In utero exposure to CB-153 and p,p′-DDE was not associated with parentally retrospectively assessed
developmental milestones in infancy or parentally assessed motor skills at young school age. The use of a more sensitive
outcome measure may be warranted if subtle effects should be identified.
Keywords: Child motor development, Developmental milestones, Dichlorodiphenyldichloroethylene (DDE),
Organochlorines, Polychlorinated biphenyls (PCBs), Prenatal exposureBackground
Polychlorinated biphenyls (PCBs) have been widely used in
industrial production, e.g. in capacitors, sealants, plasti-
cizers, fire retardants and hydraulic fluids, but they were
banned in the late 1970s in the United States and the early
1980s in Europe because of their environmental persistence
[1,2]. Also, the insecticide dichlorodiphenyltrichloroethane
(DDT) and its main metabolite dichlorodiphenyldichlor-
oethylene (DDE) are highly persistent in the environment,
and although the agricultural use of DDT has been severely* Correspondence: birghoey@rm.dk
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[3], it is still used as disease vector control in some develop-
ing countries [4]. PCBs and DDE are lipophilic compounds
which bio-accumulate in adipose tissue and, thus, the main
exposure is through food consumption and breast feeding
[5,6]. The compounds pass the placental barrier and the
fetus is exposed to approximately the same concentration
of DDE as the mother when calculated on lipid basis [7,8].
The level of PCBs in the fetus, however, seems to be some-
what lower than that of the mother although correlated [9].
PCBs and DDE can be detected in serum and breast milk
samples from almost all women around the globe, causingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the compounds during infancy [9-12].
A major contamination of rice oil by heated PCBs and
degradation products in Taiwan in 1979 gave insight into
the negative impact of high prenatal exposure on e.g.
neurodevelopment [13,14]. Animal studies later found de-
creased muscular strength [15] after high prenatal exposure
to tetrachlorobiphenyl and reduced motor activity [16] after
prenatal exposure to PCBs. However, results from epi-
demiological cohort studies are inconsistent: Higher in
utero exposure to PCBs (3000- > 4000 μg/L) was related to
a significant decrease in motor abilities indicated by 7–8
points decrease of the Psychomotor Development Index
scores (PDI) in Bayley Scales of Infant Development (BSID)
(a screening tool measuring children’s motor and mental
abilities) compared with low exposure (0–900 μg/L) at six,
12 and 24 months in a birth cohort from North Carolina
[17,18]. The Collaborative Perinatal Project from 12 hospi-
tals in the United States found no association between
background levels (0–16.50 μg/L) of prenatal PCBs expos-
ure and motor development in terms of PDI in a sample of
prenatally PCB exposed children of 8 months of age [19]. A
two-point decrease in PDI scores for every 10-fold increase
of DDE has been observed at six months of age, but not at
12 and 24 months [20], and further, no association was
found between prenatal DDE and motor development ac-
cording to McCarthy Scales of Children’s Abilities (MSCA)
in two Spanish birth cohorts [21]. In addition, no associ-
ation was found between in utero DDE exposure and motor
development using BSID or MSCA among infants of one
month, toddlers of 30 months or children of 3.5-5 years
[22-24]. However, in utero exposure to DDE has been asso-
ciated with hyporeflexia at one month in a cohort of North
American children [25] and 4 points lower PDI for each
doubling of DDE [26]. Further, no inverse associations be-
tween prenatal DDE and motor skills were observed in later
follow-ups of the large North Carolina cohort [17,18].
In this cohort, we follow three populations of 1,103
children from Arctic and Europe with a large exposure
span, which enables us to examine the relation between
different levels of organochlorine exposures and child
motor development in various parts of the world. Thus,
the aim of this follow-up study was to examine the
relations between prenatal exposure to p,p′-DDE and
CB-153 and developmental milestones in infancy mea-
sured retrospectively and motor development assessed
by the questionnaire “Developmental Coordination
Disorder Questionnaire” in five to nine year old children
in Greenland, Ukraine and Poland.
Methods
Study population
Between May 2002 and February 2004, 1,441 pregnant
women were enrolled and provided a blood sample inthe INUENDO (Biopersistent organochlorines in diet
and human fertility) cohort from Greenland, Kharkiv
(Ukraine) and Warsaw (Poland). To be eligible at base-
line, the women had to be born in the country of the
study, be pregnant as well as at least 18 years of age. At
baseline, 2,478 women were eligible in Ukraine of whom
612 (25%) participated. In Greenland, 665 were eligible
and 588 (88%) participated. All Greenlandic women
were Inuits. In Poland, 690 were eligible and 258 (37%)
participated. With few exceptions, the antenatal health
programs covered all pregnant women in the localities.
At follow-up, 493 (81%) singleton children with mea-
sured exposure information were accessible and willing
to participate in Ukraine, 525 (89%) in Greenland and
92 (36%) in Poland. A total of 1,110 children were
followed-up. Further details on distribution of the study
population are provided elsewhere [27].
After recording of child birth anthropometrics shortly
after birth, the first follow-up of the cohort was con-
ducted between January 2010 and May 2012 when the
mean age of the children was 8 years in Greenland and
Poland and 7 years in Ukraine. The retrospective reports
of the developmental milestones in infancy, the chil-
dren’s motor development at follow-up, and other char-
acteristics were assessed by the parents (usually (95%)
the mother), through an interview-based questionnaire.
Mother-child-pairs were eligible for the study if the
woman had a live-born singleton baby who was still alive
at follow-up.
Ethics statement
The study was approved by local ethical committees;
Polish Bioethical Committee (approval no. 6/2002 of
3.07.2002), Ethical Committee for Human Research in
Greenland (approval no. 2010–13) and the Commission
on Ethics and Bioethics Kharkiv National Medical Univer-
sity in Ukraine (protocol number 7, October 7 2009) and
all participating parents signed informed consent.
Exposure assessment
At baseline, the women were interviewed and had a
blood sample drawn. In Greenland and Kharkiv, the
blood samples were drawn when the women were on
average 24 weeks pregnant and in Warsaw when the
women were on average 33 weeks pregnant. Ten ml
cubital vein blood samples were drawn into vacuum
tubes for serum collection without additives (Becton
Dickinson, Maylan, France). The sera were analysed
for PCBs, measured as CB-153, and DDE, measured as
p,p′-DDE, and used as bio-markers of the prenatal
exposure to the compounds. All chemical analyses
were performed at The Department of Occupational
and Environmental Medicine in Lund, Sweden. The sera
were analysed by gas chromatography-mass-spectrometry
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lysed twice at different days and the mean concentration
of these two determinations was used. For an estimation
of the imprecision in the method, the results of the ana-
lysed samples were divided into three equal sized groups,
one with low levels, one with medium levels and one with
the highest levels and the mean concentration for each
group were calculated. Then the relative standard devia-
tions were calculated from the duplicate determinations
[28]. These were 18% at 0.1 ng/mL (n = 990), 10% at
0.5 ng/mL (n = 990) and 10% at 2 ng/mL (n = 990) for
CB-153 and 11% at 1 ng/mL (n = 1058), 8% at 3 ng/mL
(n = 1058) and 7% at 8 ng/mL (n = 1058) for p,p′-DDE.
The detection limits were 0.05 ng/mL for CB-153 and
0.1 ng/mL for p,p′-DDE. For CB-153 there was 85 sam-
ples below the detection limit (LOD) and for p,p′-DDE
there was 10 samples below LOD. If the concentration
was less than LOD, the concentration was set to half the
LOD based on fresh weight concentration. Sera were
stored at – 20°C until analysis. CB-153 and p,p′-DDE
levels were adjusted for serum concentrations of choles-
terol and triglycerides which were determined by enzym-
atic methods. The inter-assay coefficients of variation for
cholesterol and triglycerides were 1.5-2.0%. Further details
are described elsewhere [29]. The laboratory was blinded
concerning the measured outcomes and the mothers’ life-
style etc. during pregnancy.
Outcome assessment
To evaluate the motor development of the children in
the early school age, we applied the country specific
version of the Developmental Coordination Disorder Ques-
tionnaire 2007 (DCDQ’07). The DCDQ’07 is a parent re-
port measure developed to assist in the identification of
developmental coordination disorder in children between
five and 15 years, using a five-point Likert scale. It consists
of 15 items which are grouped in three factors: 1) motor
control, 2) fine motor and handwriting and 3) general co-
ordination. The sum of the age specific scores of the 15
items give an indication of whether the child suffers from a
developmental coordination disorder [30]. The sum of the
scores ranges from 15 to 75, lower scores indicating motor
problems.
At follow-up, the parents retrospectively stated the age at
which their child first crawled, stood-up with support and
walked without support, using the definitions of child devel-
opmental milestones (crawling, standing-up and walking)
from the Multicentre Growth Reference Study by the World
Health Organization [31]. Interviewers and parents were un-
aware of the level of prenatal exposure of the compounds.
Assessment of co-variates
Variables that might influence child motor development
and developmental milestones and could be associatedwith the exposures were a priori identified in the litera-
ture, and data on these were harvested from question-
naires at baseline and follow-up. Baseline variables were:
maternal pre-pregnancy smoking (yes/no), maternal pre-
pregnancy alcohol intake (≤7, >7 servings of alcohol per
week), maternal education (finished education before
age 15 years, at 16–17 years, at or above 18 years), parity
(1, 2–3, ≥4 child births), maternal age at the baseline
interview (<30, 30–35, >35 years) and gestational age at
blood drawing in weeks (continuous). Follow-up vari-
ables from immediately after birth were: sex of the child
and gestational age (<37, ≥ 37 gestational week) and
current follow-up variables were: breastfeeding (<6, 6–
12, > 12 months) and child age at interview in years
(continuous).Data collection
The interviews were primarily conducted face-to-face at
the participants’ residence or at the local hospitals in
Greenland. A medical doctor was the main interviewer
in Greenland, assisted by local health workers. A tele-
phone interview was performed when families lived in
remote areas (n = 130) or participants had moved to
Denmark (n = 34). In Poland, four interviewers con-
ducted the interviews at the participant’s residence or
other local meeting points. In Ukraine, all interviews
were conducted at eight paediatric polyclinics by a team
of 59 paediatricians. A proportion of the questionnaires
were filled in by the parents without the face-to-face
interview in Greenland. Also, one of the 15 items of the
DCDQ was erroneously lacking in the Greenlandic ver-
sion of the Questionnaire in Greenland (but not in the
Danish version used for some participants in Greenland).Statistical analyses
Missing information
A relatively large amount of the parents did not fill in all
items in the questionnaire, leading to missing data on
outcome and co-variates. If parents left one item un-
answered, it was impossible to calculate a total DCDQ
score. To overcome this and take into account that
complete case analysis may cause biased estimates of the
association under study [32], we performed chained
multiple imputations on the dataset. This approach
will result in more unbiased estimates if the data are
missing at random (the missingness is based on other
observed characteristics such as the observed outcome
or covariates) [32].
Briefly, chained multiple imputation is a statistical
method that creates several new complete datasets (m > 1),
based on known subject characteristics and other predic-
tors in the complete dataset, incorporating the appropriate
variability across the m datasets. The new m complete
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counting for the variability of the missing data [32].
We excluded subjects who had not filled in any of the
15 items in the DCDQ’07 from the chained multiple im-
putation model (n = 7), leaving a final study population
of 1,103 women and children. We made 100 imputed
datasets (m = 100) based on the following predictors:
CB-153, p,p′-DDE, maternal education, maternal age at
baseline interview, maternal pre-pregnancy smoking
status, maternal pre-pregnancy alcohol consumption,
parity, preterm birth, child sex, gestational age at blood
drawing, child age at interview, the 15 items in the
DCDQ’07, age at crawling, age at standing-up and age at
walking. We performed different sensitivity analyses of
the chained imputation models, including fewer and
more predictors and generating less (m = 20) and more
(m = 150) samples to check the robustness of the final im-
putation model. We present the results of the multiple
imputation based analyses. Results of the complete-case
analyses are available as supplementary material.Data analyses
Study subjects were divided into tertiles of CB-153 and
p,p′-DDE exposures. CB-153 and p,p′-DDE concentra-
tions were adjusted for serum lipids and thus expressed
as ng/g lipid. As a first step in the data analysis, the
correlation between CB-153 and p,p′-DDE was checked
by use of Spearman’s correlation. Secondly, the crude
relation between CB-153 and p,p′-DDE and motor de-
velopment and developmental milestones were examined
with lowest exposure tertile as the reference category.
Thirdly, the adjusted relations of prenatal exposure to CB-
153 and p,p′-DDE on motor development were examined
by means of multiple linear regression analyses with low-
est exposure tertile as the reference category. Further-
more, analyses were performed using log-transformed
continuous exposures as a test for trend. The relation
between in utero exposure to the compounds and devel-
opmental milestones was studied, using multiple linear
regression analyses, with referents as above. In a sub-
analysis, we excluded children born before gestational
week 37. A priori set variables that could affect child
motor development, based on literature studies, were in-
cluded in the regression model and kept in the model
throughout the analyses. The possible interaction between
exposures and country were tested by adding an inter-
action term (exposures*country) to the regression models.
All analyses were stratified by country as well as pooled
(additionally adjusted for country).
A p-value of 0.05 or less was considered statistically
significant. For all analyses the Stata statistical package
was used (Version 12.1, StataCorp, College Station,
Texas, USA).Results
A total of 1,103 of the 1,441 baseline participants were
included in the follow-up analyses (77%). Although the
pregnant women had to be at least 18 years of age to be
included in the study, for unknown reasons, three
women were 16 years old and 11 women were 17 years
old in Ukraine, calculated based on the recorded date
for filling in the questionnaire and date of birth.
In Greenland, Spearman’s correlation between CB-153
and p,p′-DDE was 0.9, in Poland and Ukraine, it was
0.5. The non-response analysis showed only modest
differences between responders and non-responders at
follow-up concerning exposure levels and no difference
in maternal age at birth, birth weight and gestational age
at birth (Additional file 1). Mothers were slightly older
in Poland than in the other countries and in Greenland,
the majority of the women were multiparae in contrast
to Ukraine and Poland where most women were prim-
iparae. Most mothers smoked prior to pregnancy in
Greenland while the majority of the pregnant women
from Ukraine were non-smokers. Children were youn-
gest in Ukraine, where the mean age (SD) was 7 (1) years
at follow-up. In Ukraine, median (10–90 percentile) de-
velopmental coordination disorder score (DCD) among
the children <8 years of age was 47 (37–55) points and
47 (29–58) points among the children ≥8 years of age,
while it was 62 (49–73) and 62 (29–58) points, respect-
ively in Greenland and 64 (51–73) and 67 (58–74)
points, respectively in Poland (Table 1).
As seen in Table 2, Greenlanders were most heavily
exposed to CB-153, and Ukrainians were most heavily
exposed to p,p′-DDE. The median (10–90 percentile)
serum levels of CB-153 not adjusted for lipids were
equivalent to 0.3 (0.1-1.7) μg/L in the total population
and the ditto p,p′-DDE was 3.4 (1.0-8.7) μg/L (data not
shown). The proportions of missing values are presented
in Table 3. Missing values range from 0 to 59%, mainly
due to self-administration of a proportion of the
Greenlandic questionnaires. The median missing an-
swers in the DCDQ items were 2%.
Crude results are presented as supplementary material
(Additional file 2 and Additional file 3). Medium CB-153
levels was positively associated with age at standing and
walking in the total population, corresponding to ap-
proximately two weeks delay, compared to low exposed
children. No associations were observed in the high ex-
posed group, in analyses stratified by country or between
DDE and either outcome.
In Table 4, results from the multiple imputation based
analyses are presented, showing the adjusted mean
differences of the developmental milestones crawling,
standing-up and walking. We observed no associations
between the exposures and the developmental mile-
stones. Only very modest differences were seen between
Table 1 Characteristics of mothers and their children








Age at baseline interview
(years), mean (SD)
27 (6) 25 (5) 29 (3)
Parity, child, n (%)
1st 164 (33) 401 (82) 86 (95)
2nd/3rd 244 (49) 91 (18) 5 (5)
4th or more 88 (18) 0 (0) 0 (0.0)
Smoking before pregnancy,
n (%)
Yes 379 (87) 112 (31) 18 (47)
No 55 (13) 250 (69) 20 (53)
Alcohol before pregnancy,
n (%)
≤7 servings/week 460 (88) 492 (100) 86 (95)




≤15 44 (10) 25 (6) 0 (0)
16-17 169 (36) 116 (27) 0 (0)
≥18 248 (54) 292 (67) 89 (100)
Child
Sex, n (%)
Male 280 (54) 260 (53) 54 (59)
Female 238 (46) 229 (47) 37 (41)
Age at follow-up (years),
mean (SD)
8 (1) 7 (1) 8 (1)
Breastfeeding duration
(months), n (%)
0 17 (4) 42 (9) 2 (2)
<6 118 (25) 164 (33) 19 (21)
6-12 124 (26) 177 (36) 37 (41)
>12 211 (45) 107 (22) 33 (36)
Gestational age at birth
(weeks), n (%)
≥37 496 (95) 483 (98) 87 (96)




107 (30–369) 27 (11–54) 11 (3–24)
p,p′-DDE ng/g lipid,
Median (10–90 percentile)




6.5 (2) 6.9 (2) 9.0 (8)
Standing-up (months),
Mean age (SD)
8.8 (2) 8.9 (3) 9.8 (5)
Table 1 Characteristics of mothers and their children
(born 2002–2004), INUENDO cohort (Continued)
Walking (months),
mean age (SD)
12.2 (2) 11.2 (1) 12.6 (4)
DCDQ-score < 8 years
(points) Median
[10–90 percentile]
62 [49–73] 46 [37–55] 64 [51–73]
DCDQ-score ≥ 8 years
(points) Median
[10–90 percentile]
62 [51–75] 47 [29–58] 67 [58–74]
Abbreviations: CB-153 2,2′,4,4′,5,5′-hexachlorobiphenyl, DCDQ Developmental
Coordination Disorder Questionnaire, p,p′-DDE 1,1-dichloro-2,2-bis(p-chlorophenyl)-
ethylene, SD standard deviation.
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analysis. We found the most distinct differences of mean
age at crawling in Poland, with a difference of 1.5 (95%
confidence interval (CI): −5.5, 2.5) months between low
and medium CB-153 exposed groups and a difference of
1.8 (CI: −5.7, 2.1) months between medium and low
p,p′-DDE exposed groups. Both estimates have wide
confidence intervals and are not statistically signifi-
cantly different from zero, and the results comparing
the high exposure group with the low exposure groups
are consistent with the rest of the results, indicating no
difference according to exposure levels.
Table 5 shows results from the multiple imputation
based analyses of CB-153 and p,p′-DDE and motor skills
measured as developmental coordination disorder. No
statistically significant differences were seen in any of
the three countries or in the pooled analysis.
When restricting our analyses to subjects with complete
information, we did not observe any associations between
maternal serum CB-153 and p,p′-DDE levels and either of
the child’s developmental milestones in any of the three
countries or in the pooled analysis (Additional file 4)
except for mean age at walking that appeared to be slightly
lower at higher serum p,p′-DDE levels in Greenland (p for
trend, 0.04). In Poland, medium CB-153 exposed children
had a lower mean age at standing compared to low
exposed children; −1.0 (CI: −1.9, 0.1) months. In the
complete-case analysis, results of adjusted mean differences
between tertiles of CB-153 and p,p′-DDE exposures and
parentally assessed motor skills at young school age are
similar to the results of the multiple imputation based ana-
lyses (Additional file 5).
Using breastfeeding duration as the exposure in a sub-
analysis, we found no relation to motor scores (data not
shown). Excluding 37 preterm children in a sub-analysis
gave roughly the same results except for a borderline
statistically significant difference in Greenland. High
DDE exposed children walked 0.7 months later than low
exposed children (−0.7 (95% CI:-1.4; 0.0)).
The four different sensitivity analyses performed on
the imputation model did not change the direction or











CB-153 Low 2.6-74.9 2.4-20.4 2.5-7.3 2.4-26.8
Medium 75.0-167.9 20.5-34.5 7.4-13.3 26.9-75.0
High 168.0-2,223.7 34.6-533.4 13.4-74.8 75.1-2,223.7
p,p′-DDE Low 5.3-208.9 147.0-488.3 88.3-302.8 5.3-330.5
Medium 209.0-445.0 488.4-790.6 302.9-471.2 330.6-636.0
High 445.1-3,122.0 790.7-4,835.7 471.3-1,750.1 636.1-4,835.7
Abbreviations: CB-153 2,2′,4,4′,5,5′-hexachlorobiphenyl p,p′-DDE 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene.
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stratification by maternal education gave no clear dose–
response association according to maternal education.
When testing for interaction between the exposures and
country, no apparent signs of interaction were found.Discussion
We investigated whether in utero exposure to p,p′-DDE
and CB-153 was related to parentally retrospectively
assessed delayed developmental milestones as age at
crawling, standing-up and walking in infancy, and motor
skills at 5–9 years of age as measured by DCDQ. We did
not observe any adverse association of prenatal exposure
to CB-153 and p,p′-DDE on developmental milestones








n (%) n (%) n (%)
Exposures
Prenatal exposures 0 (0.0) 0 (0) 0 (0)
Motor skills
DCDQ-score 306 (59) 11 (2) 3 (3)
Crawling 114 (22) 14 (3) 29 (32)
Standing 174 (34) 7 (1) 17 (19)
Walking 47 (9) 3 (1) 3 (3)
Maternal and child characteristics
Maternal age at baseline 37 (7) 25 (5) 0 (0)
Parity 25 (5) 0 (0) 0 (0)
Smoking before pregnancy 0 (0) 0 (0) 0 (0)
Alcohol before pregnancy 0 (0) 0 (0) 0 (0)
Maternal educational level 59 (11) 59 (12) 2 (2)
Child sex 2 (0) 3 (1) 0 (0)
Breast feeding 50 (10) 3 (1) 0 (0)
Gestational age at birth 0 (0) 0 (0) 0 (0)
Child age at follow-up 52 (10) 5 (1) 0 (0)
Abbreviations: DCDQ developmental coordination disorder questionnaire.Our results are consistent with some earlier studies
with generally lower exposure levels [19,23,33]. Daniels
et al. reported no association between PCBs (median
(95% CI): 2.7 (1.8, 3.7) ng/ml) and motor skills in terms
of BSID among 8 months old infants [19], in line with a
Canadian study among 5 year-old Inuits (CB-153 mean:
99.6 ng/g lipid) [33] and a Mexican study of DDE (mean:
6.3 ng/ml) and motor skills in 30 months old children [23].
Studies with large exposure contrast between studies
have found negative associations between in utero ex-
posure to either or both of the compounds and parts of
the motor development [17,20,25,26,34,35]. Some of the
early studies on very high levels of maternal DDE (range:
0- > 6 mg/L in milk fat) and PCBs (range: 0- > 4 mg/L in
milk fat) exposure and motor development in the off-
spring observed associations between PCBs and statisti-
cally significantly lower motor developmental scores
according to BSID and between DDE and hyporeflexia
according to Brazelton Neonatal Behavioral Assessment
Scale in the same cohort [18,25]. The discrepancies in
results could be due to the higher exposure levels and
their use of other, and more detailed, outcome measure.
Among 92 toddlers, prenatal exposure to DDE has
also been associated with lower PDI scores in Spain [26].
The age difference between the children of the cohorts
and our use of a less detailed outcome measures could
be the reason for the disparate results. A study found a
10-fold higher prenatal DDT exposure to be associated
with a two-point lower psycho-motor development BSID
score at six and 12 month old infants. High DDE-levels
(geometric mean 1,437 ng/g lipid) were also associated
to lower psycho-motor development scores at six
months but not at 12 or 24 months, indicating DDT to
be a psycho-motor toxic compound as well as DDE [20].
Mean DDE-levels in the study by Eskenazi et al. is more
than twice the level of the highest mean level in our
study and their use the more detailed BSID question-
naire, may explain the dissimilarities in results.
Breastfeeding may potentially confound the results due
to its association to postnatal exposure to PCBs and DDE.
On the other hand, recent studies have found breastfeed-
ing beneficial in relation to motor development, seemingly
Table 4 Mean differences (months)a for developmental milestones in relation to maternal tertiles of CB-153 and p,p′-DDE










































































































































































Abbreviations: CB-153 2,2′,4,4′,5,5′-hexachlorobiphenyl, CI confidence interval, Cont. Continuous, Diff. adjusted mean difference (months), p,p′-DDE 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene. aAdjusted for: maternal pre-pregnancy
smoking, maternal pre-pregnancy alcohol-intake, maternal education, parity, maternal age at baseline interview, breast-feeding, preterm birth, gestational age at blood-sampling, child sex and child age at interview. Low exposure is














Table 5 Mean differences (points)a for DCDQ-score in relation to pregnancy tertiles of CB-153 and p,p′-DDE










































































Abbreviations: CB-153 2,2′,4,4′,5,5′-hexachlorobiphenyl, CI confidence interval, Cont. Continuous, DCDQ developmental coordination disorder questionnaire, Diff adjusted mean difference (points), p,p′-DDE 1,1-dichloro-2,2-bis(p-
chlorophenyl)-ethylene, Ref. reference group. aAdjusted for: maternal pre-pregnancy smoking, maternal pre-pregnancy alcohol-intake, maternal education, parity, maternal age at birth, breast-feeding, preterm birth, gestational
age at blood-sampling, child sex and child age at interview. Low exposure is the reference group.














Høyer et al. BMC Public Health  (2015) 15:146 Page 9 of 11counterbalancing the possible negative consequences of
DDE [20,26]. In our data, breastfeeding does not seem to
be a risk or protective factor for motor development nei-
ther in general nor when stratified by prenatal exposure
levels (data not shown). We did not intend to evaluate the
associations between postnatal CB-153 or DDE exposure
and motor development in the present study.
In this study, the blood sample was drawn in the sec-
ond or third trimester of pregnancy as did many others
[19,20,34,36]. As the half-life of both compounds of
interest is several years in the human body it seems un-
likely that large differences in concentration appear be-
tween trimesters of pregnancy. However, high levels of
first trimester DDE has been associated with motor de-
velopment in infants till the age of 12 months, whereas
no association was seen between second and third tri-
mester DDE and motor development [37]. This may be
a chance finding since their study, to the best of our
knowledge, is the only one reporting such results. Also,
Longnecker et al. found the level of DDE to be highly
correlated through the trimesters of pregnancy and they
concluded that the timing of measurement was not im-
portant [38].
The three diverse populations of this study have en-
abled us to follow children in different settings with a
large exposure span. The long follow-up of up till 9 years
is important since it is of importance to disclose whether
possible associations between prenatal organochlorine
exposure and motor skills persist into school age. In
addition, these associations have rarely been investigated
in these populations.
This study has some limitations. Developmental mile-
stones were assessed retrospectively, introducing the
possibility of information bias. However, we have no rea-
son to believe that differential misclassification by expos-
ure levels has affected the estimates as parents were
unaware of their exposure levels when answering the
questionnaire. However, non-differential misclassifica-
tion may have attenuated the true association.
We did have a considerable proportion of missing data
in the dataset, in particular on the total DCDQ-score in
Greenland. In the Greenlandic version of the question-
naire (as opposed to the Danish version) one item lacked
due to an error, making a calculation of the total score
impossible in the Greenlandic version before imputation.
Thus, we performed chained multiple imputation on the
dataset because of concern for selection bias caused by
missing information. Analyses on a full dataset with no
missing items would have been preferable, however,
when missing data does occur and data is missing at
random, multiple imputation is superior to complete
case analyses [39].
The median DCDQ-score was lower in Ukraine than
in Greenland and Poland. This may be due to culturaldifferences among study sites, which has been previously
reported [31]. The reliability and validity of DCDQ is ac-
ceptable [40] although previous studies have indicated
that the original DCDQ may have poor sensitivity in a
population sample compared to the physical motor test
The Movement Assessment Battery for Children (MABC)
[41] and also, the later version, DCDQ’07, had low specifi-
city when screening an adolescent population [42]. As we
intended to examine whether there was a difference in
motor score according to exposure levels of DDE and CB-
153, we do not believe this is of major concern for our
study. In spite of a reported agreement of between 80 and
95% between DCDQ and expert opinion [40] interpret-
ation of the prevalence of DCD in the various countries is
not recommended without an additional standardized
motor test to confirm the screening result of DCDQ.
Because of a relatively small study population in
Poland and a substantial amount of covariates in the re-
gression model, the results from Poland should be inter-
preted with caution. In Poland, the participation rates at
baseline and at follow-up were rather modest (37% and
36%, respectively) and thus, the Polish part of the cohort
may not fully reflect the reference population. In Ukraine,
the baseline participation rate was quite low (25%) but
very high at follow-up (81%). The participation rates in
Greenland were very high both at baseline (88%) and at
follow-up (89%) suggesting a good representation of
the reference population in Greenland. Unfortunately,
we were not able to compare non-participating and
participating women at baseline. Comparison of re-
spondents and non-respondents at follow-up indicate
no large differences, however, loss to follow-up in par-
ticular in Poland, may have caused selection bias.
The relatively high correlation between CB-153 and
DDE made us choose not to perform mutual adjustment
in the analyses, and thus possible confounding of the
opposite organochlorines in the results could not be
eliminated.
Smoking and drinking alcohol prior to pregnancy were
used as proxies for the habits during pregnancy as this
information was unavailable. This may have lead to con-
founding of the estimates, as the women may have chan-
ged their behavior during pregnancy.
Omega-3 fatty acids may be positively related to motor
development [43] and would co-occur with the exposures.
Unfortunately we have no specific information on omega-
3 fatty acid consumption, and thus, we cannot rule out the
possibility of omega-3 fatty acid counterbalancing the pos-
sible negative effects of the organochlorines.
The results of this follow-up study show consistently
no indication of an adverse effect of prenatal exposure
to CB-153 and p,p′-DDE on motor development in
Arctic as well as in European countries representing
countries with markedly different exposure levels. However,
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153 and DDE and motor skills may be due to generally low
exposure levels or a lack of variability in range of the
exposures or both, compared to earlier studies. Also, devel-
opmental retrospectively recalled milestone may not be
sensible enough to detect a difference according to ex-
posures at these levels. The use of current motor skills
(DCDQ) at school age, on the other hand are not
prone to recall bias.
Conclusions
Prenatal exposure to CB-153 and p,p′-DDE were not as-
sociated with the parentally retrospectively assessed de-
velopmental milestones, age at crawling, standing and
walking in infancy or parentally assessed motor skills in
young school age children from Kharkiv (Ukraine),
Warsaw (Poland) and Greenland, indicating no major ef-
fect of CB-153 or p,p′-DDE exposure on these out-
comes. However, subtle effects cannot be excluded and
the use of a more sensitive outcome measure may be
warranted.
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